Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
87 participants
OBSERVATIONAL
2021-09-29
2025-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Biodesign® Otologic Graft in Tympanoplasty
NCT03904316
Use of Biodesign® Otologic Graft in Canal Wall Down Mastoidectomy: A Prospective, Randomized Trial
NCT03902938
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
NCT02307916
In-office Repair of Chronic Tympanic Membrane Perforations
NCT06448039
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NCT06293482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biodesign Otologic Repair Graft
The Biodesign Otologic Repair Graft is intended for use as grafting material for tympanic membrane perforation closure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known sensitivity to porcine material
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook Research Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IU Health
Indianapolis, Indiana, United States
Cincinnati Children's Hospital
Cincinnati, Ohio, United States
University Hospitals-Cleveland
Cleveland, Ohio, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Gloucestershire Royal Hospital
Gloucester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.